Eighteen research firms covering Morgan Stanley have assigned the stock a consensus recommendation of Moderate Buy, with eight issuing Buy ratings, three Strong Buy and seven Hold. Over the past quarter, several notable brokerages have revised their outlooks upward: one upgraded to Outperform and raised its target, another moved from Peer Perform to Outperform, while two others increased their neutral price objectives. These shifts reflect growing confidence in Morgan Stanley’s diversified revenue streams and capital markets leadership as the firm navigates a rising interest-rate environment.

In a recent Form 4 filing, CEO Edward Pick sold 100,000 shares, representing a near 15% reduction in his personal stake, generating proceeds in the mid-eight-figure range. Corporate insiders now own just under 0.2% of the company’s shares outstanding. Meanwhile, key institutional investors have been adding to their positions: Vanguard increased its holdings by roughly 1%, Capital International Investors by 0.6%, Fisher Asset Management by 1.9%, and Ameriprise Financial by just over 6%. Together, hedge funds and asset managers account for more than 84% of Morgan Stanley’s shareholder base, underscoring heavy institutional conviction.

Morgan Stanley reported third-quarter earnings per share of $2.80, comfortably exceeding consensus estimates by approximately 35%. Revenue grew nearly 19% year-over-year to just under $18 billion, driven by strength in both Institutional Securities and Wealth Management. Net margin expanded to 13.9% and return on equity climbed to 16.4%. The board declared a quarterly dividend of $1.00 per share, maintaining a payout ratio near 41% and delivering an annualized yield of roughly 2.2% to shareholders.